ARS Pharmaceuticals, Inc. (SPRY)
5.79
+0.02
(+0.35%)
USD |
NASDAQ |
Sep 02, 14:16
ARS Pharmaceuticals Net Income (TTM) : -215.43M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -215.43M |
| March 31, 2026 | -197.98M |
| December 31, 2025 | -171.30M |
| September 30, 2025 | -80.04M |
| June 30, 2025 | -48.02M |
| March 31, 2025 | -15.65M |
| December 31, 2024 | 7.998M |
| September 30, 2024 | -49.10M |
| June 30, 2024 | -44.84M |
| March 31, 2024 | -49.70M |
| December 31, 2023 | -54.36M |
| September 30, 2023 | -19.96M |
| Date | Value |
|---|---|
| June 30, 2023 | -11.67M |
| March 31, 2023 | -0.722M |
| December 31, 2022 | 6.989M |
| September 30, 2022 | -43.71M |
| June 30, 2022 | -59.78M |
| March 31, 2022 | -77.86M |
| December 31, 2021 | -89.48M |
| September 30, 2021 | -79.10M |
| June 30, 2021 | -64.56M |
| March 31, 2021 | -46.54M |
| December 31, 2020 | -32.95M |
| September 30, 2020 | -26.83M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Passage Bio, Inc. | -36.11M |
| Vertex Pharmaceuticals, Inc. | 4.405B |
| Capricor Therapeutics, Inc. | -129.42M |
| Kyntra Bio, Inc. | -30.91M |
| Zentalis Pharmaceuticals, Inc. | -139.54M |